Novel Plasmodium falciparum histidine-rich protein 2/3 repeat type in Ethiopian malaria infection: does this affect performance of HRP2-based malaria RDT?

• Published in: Malaria journal Vol. 23; no. 1; pp. 262 - 12
• Main Authors: Mandefro, Aynalem, Kebede, Alebachew Messele, Mekonen, Bacha, Katsvanga, Mitchel, Cham, Fatoumatta, Etoketim, Blessed, Oriero, Eniyou, Amambua-Ngwa, Alfred, Golassa, Lemu
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 29.08.2024; BioMed Central; BMC
• Subjects: Adolescent; Adult; Amino acid sequence; Antigens, Protozoan - genetics; Blood proteins; Child; Child, Preschool; Cross-Sectional Studies; Diagnostic Tests, Routine; Discovery and exploration; Entomology; Ethiopia; Female; Genetic Variation; Humans; Infant; Malaria; Malaria, Falciparum - parasitology; Male; Medical tests; Middle Aged; PfHRP2/3; Physiological aspects; Plasmodium falciparum; Plasmodium falciparum - genetics; Protozoan Proteins - genetics; RDT; Repeat type; Young Adult; Ethiopia; Amino acid sequence; PfHRP2/3; RDT; Malaria; Repeat type; Ethiopia
• ISSN: 1475-2875; 1475-2875
• DOI: 10.1186/s12936-024-05093-9

Rapid diagnostic tests (RDTs) provide quick, easy, and convenient early diagnosis of malaria ensuring better case management particularly in resource-constrained settings. Nevertheless, the efficiency of HRP2-based RDT can be compromised by Plasmodium falciparum histidine-rich protein 2/3 gene deletion and genetic diversity. This study explored the genetic diversity of PfHRP2/3 in uncomplicated malaria cases from Ethiopia. A cross-sectional study was conducted from June 2022 to March 2023 at Metehara, Zenzelema and Kolla Shele health centres, Ethiopia. Finger-prick blood samples were collected for RDT testing and microscopic examination. For molecular analysis, parasite genomic DNA was extracted from venous blood. Plasmodium falciparum was confirmed using VarATS real time PCR. Additionally, PfHRP2/3 was amplified, and DNA amplicons were sequenced using Oxford Nanopore technology. PfHRP2/3 sequences revealed small variations in the frequency and number of amino acid repeat types per isolate across the three health centres. Twelve and eight types of amino acid repeats were identified for PfHRP2 and PfHRP3, respectively, which had been previously characterized. Repeat type 1, 4 and 7 were present in both PfHRP2 and PfHRP3 amino acid sequences. Type 2 and 7 repeats were commonly dispersed in PfHRP2, while repeat types 16 and 17 were found only in PfHRP3. A novel 17 V repeat type variant, which has never been reported in Ethiopia, was identified in six PfHRP3 amino acid sequences. The majority of the isolates, as determined by the Baker's logistic regression model, belonged to group C, of which 86% of them were sensitive to PfHRP2-based RDT. Likewise, PfHRP2-based RDT detected 100% of the isolates in group A (product of type 2 × type 7 repeats ≥ 100) and 85.7% in group B (product of types 2 × type 7 repeats 50-99) at a parasitaemia level > 250 parasite/μl. This study highlights the significant diversity observed in PfHRP2 and PfHRP3 among clinical isolates of Plasmodium falciparum in Ethiopia. This emphasizes the necessity for monitoring of PfHRP2- based RDT efficacy and their repeat type distribution using a large sample size and isolates from various ecological settings.